Literature DB >> 24621918

The etiology of glomerulonephritis: roles of infection and autoimmunity.

William G Couser1, Richard J Johnson2.   

Abstract

Despite major advances in understanding genetic predispositions ('first hits'), pathogenic immune responses, and the mediators of tissue injury in glomerulonephritis (GN), there remains a dearth of knowledge about the etiologic events, or 'second hits', which trigger these diseases. This paper reviews evidence that infections initiate most forms of GN through numerous simultaneous and/or sequential pathways that begin with activation of the innate immune response and lead to autoimmunity. These pathways include immune dysregulation, adjuvant or bystander effects, epitope spreading, molecular mimicry, epitope conformational changes, and antigen complementarity that, in genetically susceptible individuals, result in the nephritogenic autoimmune responses that underlie GN. Infections may also have direct effects on glomerular cells. Rapid expansion in knowledge of the microbiome and its role in health and disease, as well as systems biology approaches to glomerular disease offer the potential to develop preventive approaches to GNs that can now be treated only with immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24621918     DOI: 10.1038/ki.2014.49

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  47 in total

Review 1.  Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.

Authors:  Laura H Mariani; William F Pendergraft; Matthias Kretzler
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-14       Impact factor: 8.237

Review 2.  Plasma cells as an innovative target in autoimmune disease with renal manifestations.

Authors:  Falk Hiepe; Andreas Radbruch
Journal:  Nat Rev Nephrol       Date:  2016-02-29       Impact factor: 28.314

3.  The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.

Authors:  Li-Jun Xie; Zhao Cui; Fang-Jin Chen; Zhi-Yong Pei; Shui-Yi Hu; Qiu-Hua Gu; Xiao-Yu Jia; Li Zhu; Xu-Jie Zhou; Hong Zhang; Yun-Hua Liao; Lu-Hua Lai; Billy G Hudson; Ming-Hui Zhao
Journal:  Immunology       Date:  2017-05-16       Impact factor: 7.397

4.  Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from Actinomyces.

Authors:  Qiu-Hua Gu; Megan Huynh; Yue Shi; Xiao-Yu Jia; Jie-Jian Luo; Tai-Jiao Jiang; Zhao Cui; Joshua D Ooi; A Richard Kitching; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2020-06       Impact factor: 10.121

Review 5.  Viral-Associated GN: Hepatitis C and HIV.

Authors:  Warren L Kupin
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 6.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

Review 7.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

8.  Transmission of a Novel Genotype of Hepatitis E Virus from Bactrian Camels to Cynomolgus Macaques.

Authors:  Lin Wang; Jade L L Teng; Susanna K P Lau; Siddharth Sridhar; Hongwei Fu; Wanyun Gong; Manyu Li; Qieshi Xu; Yunye He; Hui Zhuang; Patrick C Y Woo; Ling Wang
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

9.  Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies.

Authors:  Michelle Willicombe; Jill Moss; Linda Moran; Paul Brookes; Eva Santos-Nunez; Adam G McLean; Thomas Cairns; David Taube; Terence H Cook; Candice Roufosse
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

10.  What is myeloperoxidase doing in ANCA-associated glomerulonephritis?

Authors:  William G Couser; Richard J Johnson
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.